###begin article-title 0
Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity
###end article-title 0
###begin p 1
###xml 38 54 38 54 <email xmlns:xlink="http://www.w3.org/1999/xlink">vwallace@ohri.ca</email>
Correspondence to Valerie A. Wallace: vwallace@ohri.ca
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
Sonic hedgehog (Shh) is an indispensable, extrinsic cue that regulates progenitor and stem cell behavior in the developing and adult mammalian central nervous system. Here, we investigate the link between the Shh signaling pathway and Hes1, a classical Notch target. We show that Shh-driven stabilization of Hes1 is independent of Notch signaling and requires the Shh effector Gli2. We identify Gli2 as a primary mediator of this response by showing that Gli2 is required for Hh (Hedgehog)-dependent up-regulation of Hes1. We also show using chromatin immunoprecipitation that Gli2 binds to the Hes1 promoter, which suggests that Hes1 is a Hh-dependent direct target of Gli2 signaling. Finally, we show that Shh stimulation of progenitor proliferation and cell diversification requires Gli2 and Hes1 activity. This paper is the first demonstration of the mechanistic and functional link between Shh, Gli, and Hes1 in the regulation of progenitor cell behavior.
###end p 3
###begin p 4
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 184 185 184 185 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
Abbreviations used in this paper: ChIP, chromatin immunoprecipitation; CNS, central nervous system; CRALBP, cellular retinaldehyde-binding protein; DAPT, N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester; DIV, days in vitro; E, embryonic day; Hh, Hedgehog; IHC, immunohistochemistry; ISH, in situ hybridization; P, postnatal day; Ptch, Patched; RGC, retinal ganglion cell; RPC, retinal progenitor cell; RT-qPCR, quantitative RT-PCR; Shh, Sonic hedgehog; Smo, Smoothened.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 450 472 450 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Donovan and Dyer, 2005</xref>
###xml 585 596 585 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">Young, 1985</xref>
###xml 598 616 598 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Cepko et al., 1996</xref>
###xml 772 793 772 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">Waid and McLoon, 1998</xref>
###xml 795 817 795 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Belliveau et al., 2000</xref>
###xml 819 839 819 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib72">Zhang and Yang, 2001</xref>
###xml 841 863 841 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Cayouette et al., 2003</xref>
###xml 865 881 865 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Kim et al., 2005</xref>
The neural retina represents an attractive model for investigating the molecular basis of progenitor cell proliferation and cell fate diversification in the central nervous system (CNS). The advantages of the retinal model system arise from the capacity for in vivo and in vitro analyses, the limited number of neurons and glial cell types comprising the mature retina, and the high degree of conservation of many developmental signaling mechanisms (Donovan and Dyer, 2005). The retinal cell types are derived in a temporal sequence from a common pool of multipotent progenitor cells (Young, 1985; Cepko et al., 1996). This conserved birth order is dependent on both intrinsic changes in competence of progenitor cells as well as cellular responses to environmental cues (Waid and McLoon, 1998; Belliveau et al., 2000; Zhang and Yang, 2001; Cayouette et al., 2003; Kim et al., 2005).
###end p 6
###begin p 7
###xml 198 223 198 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Marti and Bovolenta, 2002</xref>
###xml 225 249 225 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Dakubo and Wallace, 2004</xref>
###xml 622 648 622 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">Villavicencio et al., 2000</xref>
The Sonic hedgehog (Shh) pathway is a highly conserved cell extrinsic regulator of progenitor cell proliferation and diversification in many tissues, including the developing CNS and neural retina (Marti and Bovolenta, 2002; Dakubo and Wallace, 2004). Patched (Ptch) is the transmembrane receptor for Shh and normally antagonizes the activity of the transmembrane protein Smoothened (Smo), which is required for the activation of the Gli zinc finger transcription factors. Shh binding to Ptch alleviates the Ptch-mediated repression of Smo, allowing activation of Gli transcription factors and expression of target genes (Villavicencio et al., 2000).
###end p 7
###begin p 8
###xml 128 145 128 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 215 239 215 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Jensen and Wallace, 1997</xref>
###xml 241 260 241 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Levine et al., 1997</xref>
###xml 262 280 262 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Black et al., 2003</xref>
###xml 282 303 282 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Moshiri and Reh, 2004</xref>
###xml 305 325 305 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Moshiri et al., 2005</xref>
###xml 327 344 327 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 485 502 485 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 525 528 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 661 678 661 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 938 955 938 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">Wang et al., 2002</xref>
###xml 1178 1195 1178 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 1197 1216 1197 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Locker et al., 2006</xref>
###xml 1236 1245 1236 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyclin D1</italic>
###xml 1341 1356 1341 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Ma et al., 1998</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 546 551 <span type="species:ncbi:10090">mouse</span>
In the mouse retina, Shh is secreted from postmitotic retinal ganglion cells (RGCs) and targets retinal progenitor cells (RPCs; Wang et al., 2005). Activation of the Shh pathway increases the proliferation of RPCs (Jensen and Wallace, 1997; Levine et al., 1997; Black et al., 2003; Moshiri and Reh, 2004; Moshiri et al., 2005; Wang et al., 2005), whereas conditional inactivation of Shh results in decreased numbers of progenitor cells, confirming a role for Shh in RPC proliferation (Wang et al., 2005). Genetic ablation of Shh in the embryonic mouse retina also results in increased RGC production, revealing a role for Shh signaling in cell fate regulation (Wang et al., 2005). During later stages of retinal development, loss of Shh signaling results in a reduction of Muller glial cells and bipolar neurons, which is only restored with Shh pathway activation, indicating a potential instructive role for Shh in specifying cell fate (Wang et al., 2002). Few Gli target genes important for these Shh-induced cellular responses have been identified. Cyclin D1, the major D-type cyclin expressed in the retina, is a reported target of Shh signaling during retinal development (Wang et al., 2005; Locker et al., 2006). However, loss of Cyclin D1 in the retina does not recapitulate the cell fate changes observed with loss of Shh signaling (Ma et al., 1998), which indicates that other unidentified targets of Shh/Gli signaling are necessary for establishing Shh-dependent effects.
###end p 8
###begin p 9
###xml 171 192 171 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Kageyama et al., 2005</xref>
###xml 462 483 462 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Furukawa et al., 2000</xref>
###xml 485 507 485 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Takatsuka et al., 2004</xref>
###xml 509 531 509 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Hashimoto et al., 2006</xref>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 717 739 717 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Takatsuka et al., 2004</xref>
###xml 741 758 741 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 912 931 912 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Jadhav et al., 2006</xref>
###xml 933 951 933 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">Yaron et al., 2006</xref>
###xml 1002 1007 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch</italic>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1236 1253 1236 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 400 405 <span type="species:ncbi:9031">chick</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
Hes1 is a basic helix-loop-helix (bHLH) repressor and functions as a target of Notch signaling, a pathway that plays a key role in maintaining neural progenitor identity (Kageyama et al., 2005). There are several redundant functions of Shh and Hes1 during CNS and retinal development that suggest convergence of these pathways. For example, Hes1 has been implicated in regulating cell cycling in the chick retina and Muller cell development in the mouse retina (Furukawa et al., 2000; Takatsuka et al., 2004; Hashimoto et al., 2006). Also, the retinas of Hes1 and Shh mutants are phenotypically similar, as both are characterized by an increased production of RGCs, precocious cell cycle exit, and depletion of RPCs (Takatsuka et al., 2004; Wang et al., 2005). In contrast, conditional Notch1 mouse mutants are characterized by a propensity to develop cone photoreceptors without an increase in RGC development (Jadhav et al., 2006; Yaron et al., 2006). The differing phenotypes resulting from loss of Notch and Hes1 in the retina suggest that Hes1 may have Notch-independent roles in retinal development. Furthermore, preliminary observations indicate that Shh signaling may influence the maintenance of Hes1 expression in the retina (Wang et al., 2005).
###end p 9
###begin p 10
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ</italic>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 374 382 374 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ</italic>
###xml 382 385 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptch</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 746 750 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
Here, we establish a novel, Shh-dependent regulatory mechanism for controlling neural progenitor cell behavior. Inhibition of Hes1 activity results in a decrease in RPC proliferation as well as a disruption of neuronal cell development in response to Shh pathway activation. Furthermore, the increased proliferation characterizing PtchlacZ+/- retinas is rescued in compound PtchlacZ+/-Hes1+/- heterozygous mice, which suggests that Hes1 is epistatic to Ptch and is required to potentiate the proliferative response induced by the Shh pathway in vivo. We show that modulation of Hes1 by Shh requires signaling through the activator Gli2 and is independent of the Notch pathway. Finally, chromatin immunoprecipitation (ChIP) analysis suggests that Hes1 is a Shh-dependent, direct transcriptional target of Gli2. Thus, we have identified a novel mechanism linking Shh, Gli2, and Hes1 that is important for controlling neural progenitor cell proliferation.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Hes1 is activated by Shh signaling in a temporally regulated manner
###end title 12
###begin p 13
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes</italic>
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 a</xref>
###xml 283 301 283 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib71">Zhang et al., 2002</xref>
###xml 521 538 521 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">Wang et al., 2002</xref>
###xml 589 618 589 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Frank-Kamenetsky et al., 2002</xref>
###xml 674 691 674 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes</italic>
###xml 881 885 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 892 900 880 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 b</xref>
###xml 1029 1033 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1096 1100 1084 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1156 1160 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1268 1272 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 1347 1355 1335 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 b</xref>
###xml 1383 1387 1371 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1564 1568 1552 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1650 1654 1638 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1754 1762 1742 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 b</xref>
###xml 1835 1843 1823 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 c</xref>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
To investigate the Shh dependence of Hes gene expression in RPCs, we used retina organ cultures (explants) derived from postnatal mice (Fig. 1 a). Key features of normal retinal development, including critical cell fate decisions, are recapitulated in retinal cell explant cultures (Zhang et al., 2002). We have shown previously that Shh induction of target genes is abolished in postnatal mouse retinal explants due to the death of Shh-secreting RGCs because of a lack of trophic support from target tissues in the CNS (Wang et al., 2002). We treated retinal explants with a Smo agonist (Frank-Kamenetsky et al., 2002), which restores Hedgehog (Hh) target gene expression (Wang et al., 2005), and analyzed Hes induction by quantitative RT-PCR (RT-qPCR). Activation of the Shh pathway in retinal explants derived from postnatal mice results in an approximately20-fold induction of Hes1 mRNA (Fig. 1 b). Interestingly, Shh signaling in explants cultured from embryonic day 14 (E14) retinas resulted in only a twofold induction of Hes1 mRNA, which indicates temporal regulation of the magnitude of Hes1 expression by the Shh pathway. The modest induction of Hes1 at E14 is not caused by a lack of progenitor cell competence to respond to Shh because the Hh target gene, Gli1, is potently activated by Shh in both E14 and postnatal retinal explants (Fig. 1 b). These data indicate that Hes1 is inducible by Shh signaling at developmental stages when Shh is regulating both RGC development and RPC proliferation. A similar temporal regulatory pattern was observed for Hes5 in response to Shh signaling. Shh activation resulted in a fivefold induction of Hes5 mRNA in postnatal retinal explants, whereas no significant induction was observed in E14 explants (Fig. 1 b). Shh pathway activation also results in stabilization of Hes1 protein (Fig. 1 c), whereas Hes1 protein was undetectable in untreated explants devoid of Shh ligand, which indicates that an active Hh pathway is necessary for the maintenance of Hes1 in RPCs.
###end p 13
###begin p 14
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Shh is required to maintain Hes1 protein and mRNA in postnatal retinal explants.</bold>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 711 712 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 726 727 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 769 773 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 775 779 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 785 789 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
Shh is required to maintain Hes1 protein and mRNA in postnatal retinal explants. (a) Diagram of the retinal explant culture method. Once the retina is surgically detached from the lens and surrounding ocular tissues, it is flattened by making four incisions and cultured on a membrane in the presence of a Smo agonist to activate the Hh signaling pathway. A cross section of a postnatal retinal explant is shown demonstrating Gli1 transcript expression in the Hh-responsive progenitor cells of the neuroblast region. The RGC layer is comprised of a population of postmitotic neurons that are not responsive to Hh signaling. Bar, 100 mum. (b) Retinal explants were treated with and without a Smo agonist at E14 (n = 3) and P0 (n = 3) for 3 d in culture and analyzed for Hes1, Hes5, and Gli1 mRNA by RT-qPCR. Values represent fold mRNA induction in Smo agonist-treated explants relative to untreated explants. Error bars represent SEM. *, P < 0.05. (c) Western blot for Hes1 from P0 retinal explants cultured for 3 d from untreated and Smo agonist-treated explants; beta-tubulin protein level was used as a loading control.
###end p 14
###begin title 15
Shh activation of Hes1 and Hes5 does not require the active NICD
###end title 15
###begin p 16
###xml 165 169 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 174 178 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 180 206 176 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Kageyama and Ohtsuka, 1999</xref>
###xml 245 249 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 254 258 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 358 359 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 361 362 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 388 389 380 381 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 481 500 473 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Geling et al., 2002</xref>
###xml 503 507 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 612 616 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 725 740 717 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, m and o</xref>
###xml 814 818 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 839 858 831 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Nelson et al., 2007</xref>
###xml 960 976 952 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">Xie et al., 1998</xref>
###xml 1282 1305 1274 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Matsuda and Cepko, 2004</xref>
###xml 1507 1511 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 1568 1583 1560 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, f and h</xref>
###xml 1667 1671 1659 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1676 1680 1668 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1790 1805 1782 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, l and p</xref>
###xml 1948 1952 1940 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1965 1973 1957 1965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 i</xref>
###xml 1995 1999 1987 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 2142 2146 2134 2138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
Notch is a transmembrane protein and requires cleavage by a gamma-secretase complex to free its active intracellular domain (NICD) and induce target genes including Hes1 and Hes5 (Kageyama and Ohtsuka, 1999). To address whether Shh induction of Hes1 and Hes5 requires Notch signaling, we used a widely used chemical inhibitor of the gamma-secretase complex, N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT), to inhibit propagation of the Notch pathway (Geling et al., 2002). Hes5, which is robustly expressed in untreated retinal explants, was used as a read-out for Notch signaling. Hes5 was down-regulated in DAPT-treated retinal explants, which verifies Notch inactivation with DAPT treatment (Fig. 2, m and o) and is consistent with previous reports showing the Notch dependence of Hes5 expression in RPCs (Nelson et al., 2007). Activation of the Hh pathway was accomplished using a constitutively active allele of Smo (Smo-M2; Xie et al., 1998). Transfection of RPCs was accomplished using electroporation of transgenes in retinal explants. It has been previously found that transfection efficiency of postmitotic cells in electroporated retinal explants is very low, which indicates that dividing cells are the primary targets for electroporation (Matsuda and Cepko, 2004). Retinal explants were coelectroporated with Smo-M2 and pUb-GFP to localize the transfected cells, and simultaneously treated with DAPT for Notch pathway inactivation. In situ hybridization (ISH) for Gli1 confirmed Shh pathway activation in response to Smo-M2 (Fig. 2, f and h). Induction of Shh signaling with SMO-M2 resulted in a cell-autonomous increase in Hes1 and Hes5 mRNA in the presence of DAPT, which indicates that Shh activation of these genes is independent of the NICD (Fig. 2, l and p). It is also noteworthy that control retinal explants electroporated with pUb-GFP, which do not exhibit Shh signaling, do not have detectable Hes1 expression (Fig. 2 i). Because endogenous Hes5 expression is lost with DAPT treatment, this suggests that Notch signaling is active in control retinal explants yet insufficient to maintain Hes1 expression.
###end p 16
###begin p 17
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Shh activation of <italic>Hes1</italic> and <italic>Hes5</italic> is independent of Notch signaling.</bold>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
Shh activation of Hes1 and Hes5 is independent of Notch signaling. Retinas at P0 were electroporated with SMO-M2 cotransfected with pUB-GFP or pUB-GFP alone and cultured for 3 d with DAPT or DMSO control. (a-d) GFP fluorescence localizes the transfected cells. ISH was performed for Gli1 (e-h), Hes1 (i-l), and Hes5 (m-p). Differences in the localization of transfected cells within the explants are caused by folding and twisting during tissue processing. Bars, 100 mum. (q) Retinal explants (P0 + 3 days in vitro [DIV]) were electroporated with Smo-M2/pUb-GFP, treated with DAPT, dissociated, and scored for the proportion of BrdU+GFP+/GFP+ cells. The magnitude of Smo-M2-induced proliferation is not changed with DAPT treatment. Error bars represent SEM. *, P < 0.05; **, P < 0.005.
###end p 17
###begin p 18
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 q</xref>
We also tested whether Shh activation can induce cellular proliferation in RPCs independently of Notch signaling. Retinal explants were electroporated with SMO-M2, treated with DAPT, dissociated, and scored for BrdU incorporation. Antagonizing Notch activity did not significantly affect the proliferative effect of Shh signaling, which indicates that Shh can regulate progenitor cell behavior in a Notch-independent manner (Fig. 2 q).
###end p 18
###begin title 19
Differential mechanism for the induction of Hes1 and Hes5 by Shh signaling
###end title 19
###begin p 20
###xml 34 40 34 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 367 371 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 500 521 488 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Nofziger et al., 1999</xref>
###xml 827 831 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 1010 1020 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBPJ-&#954;</italic>
###xml 1110 1114 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1197 1212 1169 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, f and l</xref>
###xml 1223 1227 1195 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1246 1250 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1297 1307 1269 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBPJ-&#954;</italic>
###xml 1319 1327 1287 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 i</xref>
###xml 1375 1379 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1428 1436 1392 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 l</xref>
###xml 1505 1509 1469 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1514 1518 1478 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1554 1558 1518 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1635 1639 1599 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
Although the previous experiment (Fig. 2) demonstrates that Shh can regulate Hes1 independently of NICD activity, it does not address whether other downstream effectors of the Notch pathway are responsible for mediating Shh-dependent Hes1 expression. We next asked whether the induction of Hes1 by the Shh pathway requires the activity of RBPJ-kappa by investigating Hes1 induction in the context of RBPJ-kappa knockdown. To control for the specificity of the shRBPJ-kappa, we show that Notch (NICD; Nofziger et al., 1999)-mediated activation of a Notch reporter in retinal explants is abrogated by coexpression of shRBPJ-kappa (Fig. S1, available at ). Retinal explants from postnatal day 0 (P0) mice were electroporated with an shRBPJ-kappa plasmid and cotransfected with pUb-GFP to localize the transfected cohort of cells. Gli1 is induced in the presence of the control and shRBPJ-kappa vectors, which indicates activation of the Shh pathway (unpublished data). ISH analysis revealed a marked reduction in RBPJ-kappa mRNA in transfected cells, which was also associated with a cell-autonomous reduction of Hes5 mRNA, which provides additional confirmation of the specificity of the knockdown (Fig. 3, f and l). ISH for Hes1 demonstrates that Hes1 is induced in RPCs by the Smo agonist despite RBPJ-kappa knockdown (Fig. 3 i). However, the Shh pathway is unable to induce Hes5 in cells expressing the shRBPJ-kappa construct (Fig. 3 l). This result infers a differential mechanism for the modulation of Hes1 and Hes5 by Shh signaling. The induction of Hes1 via Shh is independent of the Notch signaling pathway, whereas induction of Hes5 requires functional RBPJ-kappa signaling.
###end p 20
###begin p 21
###xml 58 62 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 101 105 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 0 106 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RBPJ-&#954; signaling is not required for Shh induction of <italic>Hes1</italic> but is necessary for Shh induction of <italic>Hes5</italic>.</bold>
###xml 333 343 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBPJ-&#954;</italic>
###xml 351 355 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 367 371 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 522 526 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 606 610 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
RBPJ-kappa signaling is not required for Shh induction of Hes1 but is necessary for Shh induction of Hes5. Retinal explants were electroporated with shRBPJ-kappa or a control short hairpin plasmid at P0 and cultured for 4 d with or without a Smo agonist. (a-c) GFP fluorescence localizes the transfected cells. ISH was performed for RBPJ-kappa (d-f), Hes1 (g-i), and Hes5 (j-l). Bar, 100 mum. (m) Retinal explants were coelectroporated with an empty vector control, NICD, or Smo-M2 and pUB-GFP, and cultured for 3 d, then Hes1 expression was analyzed by RT-qPCR. Values represent the relative induction of Hes1 expression normalized to GFP. Error bars represent SEM. *, P < 0.005.
###end p 21
###begin title 22
Activated Notch signaling is a weak regulator of Hes1 in RPCs
###end title 22
###begin p 23
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 m</xref>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
Because Shh-mediated induction of Hes1 is independent of Notch signaling, we wanted to compare the efficiency of the Shh and Notch pathways in activating Hes1 in RPCs. The active NICD, Smo-M2, or an empty-vector control were coelectroporated with pUB-GFP in retinal explant cultures. Hes1 expression was analyzed using RT-qPCR and normalized to GFP to account for variations in transfection efficiency. Activation of the Hh pathway resulted in a 10-fold greater Hes1 induction compared with Notch pathway activation (Fig. 3 m), which indicates that Hes1 expression in RPCs is primarily responsive to the Shh pathway when compared with Notch signaling.
###end p 23
###begin title 24
Shh induction of Hes1 requires signaling through activator Gli2
###end title 24
###begin p 25
###xml 164 181 164 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Park et al., 2000</xref>
###xml 183 199 183 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Bai et al., 2002</xref>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>&#8722;/&#8722;</sup></italic>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 396 403 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 409 423 409 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>&#8722;/&#8722;</sup>Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 633 640 633 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 746 754 746 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 884 888 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 963 966 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 970 973 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 959 973 959 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>&#8722;/&#8722;</sup>Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 1088 1092 1088 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1138 1146 1138 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 1196 1200 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1254 1258 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1284 1287 1284 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1280 1287 1280 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 1315 1323 1315 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 b</xref>
###xml 1326 1330 1326 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1384 1387 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1380 1387 1380 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 1481 1485 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
The major downstream activators of the Shh pathway are the Gli1 and Gli2 transcription factors, which activate target gene expression in response to Smo signaling (Park et al., 2000; Bai et al., 2002). Gli1 and Gli2 are also expressed in the Hh-responsive neuroblast region of the developing retina. To evaluate the role of activator Gli function in the regulation of Hes1, we generated Gli1-/-, Gli2-/-, and Gli1-/-Gli2-/- mutant mice. Retinal explants derived from these mice were cultured in the presence of Smo agonist and analyzed by RT-qPCR for induction of Hes1 mRNA. The Hh-mediated induction of Hes1 was reduced fourfold in Gli2-/- explants compared with wild-type explants, whereas loss of Gli1 signaling did not effect Hes1 induction (Fig. 4 a). These data indicate that Gli2 is the predominate factor responsible for Hes1 regulation downstream of Shh activation. However, Hes1 induction was completely attenuated in retinal explants cultured from Gli1-/-Gli2-/- compound mutant mice in response to Hh pathway activation, which indicates that Gli1 can minimally compensate for Hes1 activation in the absence of Gli2 signaling (Fig. 4 a). To establish a link between Gli2 signaling and Hes1 expression in vivo, we analyzed endogenous levels of Hes1 in acutely dissected Gli2-/- and wild-type E18 retinas (Fig. 4 b). Hes1 expression is down-regulated nearly threefold in Gli2-/- retinas compared with wild-type retinas, which establishes Gli2 as an important regulator of Hes1 expression in vivo.
###end p 25
###begin p 26
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Shh induction of <italic>Hes1</italic> requires Gli2.</bold>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>&#8722;/&#8722;</sup></italic>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 138 152 138 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup>Gli1<sup>&#8722;/&#8722;</sup></italic>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 431 438 431 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 863 867 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1121 1125 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1303 1307 1300 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1666 1670 1660 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 1733 1734 1726 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1766 1767 1759 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1798 1802 1791 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1807 1811 1800 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
Shh induction of Hes1 requires Gli2. (a) Retinal explants were cultured from wild-type (Wt; n = 5), Gli1-/- (n = 3), Gli2-/- (n = 6), and Gli2-/-Gli1-/- (n = 3) mice with or without a Smo agonist at E18 for 3 d, then analyzed for Hes1 expression by RT-qPCR. Values represent fold mRNA induction in Smo agonist-treated explants relative to untreated explants. (b) RT-qPCR on acutely dissected retinas from E18 wild-type (n = 5) and Gli2-/- (n = 5) animals. Values represent fold mRNA induction in Gli2-/- retinas compared with the wild type. The black lines in the Western blot indicate that intervening lanes have been spliced out. (c) Western blot analysis of protein lysates from Myc-Gli2-transfected or control COS cells blotted with an anti-Gli2 antibody. The beta-tubulin protein level was used as a loading control. (d) Schematic of the 10-kb region of the Hes1 promoter. The Gli2-binding sites are indicated with the mismatched nucleotides relative to the ideal Gli consensus sequence in small letters. ChIP reveals enrichment of Gli2 at sites -7,808 bp and -146 bp upstream of the transcription start site in the Hes1 promoter in retinal explants treated with a Smo agonist. No enrichment of Gli2 was detected at these sites in untreated retinal explants. Association of Gli2 at a region of the Hes1 promoter that does not contain a Gli consensus sequence was used as a negative control. (e) Western blot analysis for Gli2 on retinal explants treated with or without a Smo agonist (P0 + 3 DIV). The beta-tubulin protein level was used as a loading control. (f and g) Retinal explants cultured with or without a Smo agonist for 3 DIV and subjected to ISH for Gli2. Bars, 100 mum. (h) Retinal explants (P0) were cultured with (n = 5) or without a Smo agonist (n = 4) for 6 h and analyzed for Hes1 and Gli1 expression by RT-qPCR. Values represent fold mRNA induction in Smo agonist-treated explants relative to untreated explants. Error bars represent SEM. *, P < 0.05; **, P < 0.001.
###end p 26
###begin p 27
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 616 648 616 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Kleinjan and van Heyningen, 2005</xref>
###xml 650 665 650 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Ni et al., 2008</xref>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 861 865 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 993 997 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1251 1255 1251 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 1301 1309 1301 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 c</xref>
###xml 1348 1352 1348 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1490 1498 1490 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 d</xref>
###xml 1528 1532 1528 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1673 1677 1673 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1736 1744 1736 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 d</xref>
Because the induction of Hes1 by Shh does not require signaling through Notch but does require Gli2, we addressed whether Hes1 is a direct transcriptional target of Gli2. To study Hes1 regulation in vitro, we generated a luciferase reporter containing the Hes1 promoter and 10 kb of additional upstream sequence. The Hes1 reporter is not sufficient to mimic endogenous Hes1 activity by Hh signaling, which could indicate that we have not identified all of the relevant regulatory sequences or that the function of Gli2 in this context will not be revealed in simple reporter assays with nonchromatinized substrates (Kleinjan and van Heyningen, 2005; Ni et al., 2008). We therefore examined the possibility of Shh-mediated regulation of Hes1 in the context of native chromatin by performing ChIP. These experiments allowed us to determine whether Gli2 binds the Hes1 promoter in a physiologically relevant context. Candidate Gli consensus sequences were identified within a 10-kb region of the Hes1 promoter and analyzed for association with Gli2 in control and Smo agonist-treated retinal explants. Validation of the specificity of the Gli2 antibody used for ChIP analysis was tested by Western blotting using COS cells transfected with a full-length Gli2 expression plasmid or a GFP control plasmid (Fig. 4 c). Physical association of Gli2 at the Hes1 promoter was detected at two putative Gli consensus sequences located at -146 bp and -7,808 bp upstream of the transcription start site (Fig. 4 d). Enrichment for Gli2 at the Hes1 promoter was only detected in Smo agonist-treated explants, with no enrichment of Gli2 detected in untreated explants, which suggested that Hes1 is a Shh-dependent direct transcriptional target of Gli2 (Fig. 4 d).
###end p 27
###begin p 28
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 139 162 139 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Huntzicker et al., 2006</xref>
###xml 164 180 164 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Pan et al., 2006</xref>
###xml 485 496 485 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, e&#8211;g</xref>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
The observation that Gli2 binds the Hes1 promoter only in the presence of Shh signaling may be attributed to the stability of Gli protein (Huntzicker et al., 2006; Pan et al., 2006). To test this hypothesis, we investigated whether we can detect endogenous Gli2 protein in RPCs in the absence of Hh signaling. Western blot analysis revealed that Gli2 protein is only detected in cultures with an active Hh pathway despite the presence of Gli2 transcript in untreated retinal explants (Fig. 4, e-g). This data indicates that Hh signaling is necessary for the stability of Gli2 protein in RPCs and accounts for the Hh-dependent binding of Gli2 to the Hes1 promoter.
###end p 28
###begin p 29
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 h</xref>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
To further explore the relationship between Shh signaling and Hes1 regulation, we examined the kinetics of Hes1 induction in retinal explants. Retinal explants treated with a Smo agonist for 6 h exhibited a significant induction of Hes1 compared with untreated explants, strengthening the evidence of a direct relationship between Hes1 and Hh signaling (Fig. 4 h). This induction of Hes1 is not caused by decay of Hh signaling in untreated explants because retinal explants cultured for 6 h do not exhibit a significant decrease in levels of Gli1 or Hes1 when compared with acutely dissected retinas (Fig. S2, available at ).
###end p 29
###begin title 30
Hes1 is necessary for Shh-mediated proliferation and cell fate specification in RPCs
###end title 30
###begin p 31
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 201 212 201 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 349 367 349 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Black et al., 2003</xref>
###xml 369 390 369 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Moshiri and Reh, 2004</xref>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 516 534 516 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptch</italic>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 620 627 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptch<sup>&#8722;/&#8722;</sup></italic>
###xml 698 719 698 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Goodrich et al., 1997</xref>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 870 873 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 855 873 855 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 910 913 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 902 913 902 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 920 931 920 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, a&#8211;c</xref>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1024 1027 1024 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1009 1027 1009 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 1143 1151 1143 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ</italic>
###xml 1151 1154 1151 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1261 1269 1261 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 d</xref>
###xml 1410 1418 1410 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ</italic>
###xml 1418 1421 1418 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1530 1533 1530 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1537 1540 1537 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1522 1540 1522 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 1550 1558 1550 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 e</xref>
###xml 1655 1659 1655 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
Because we have demonstrated a novel mechanism for Hes1 regulation by Shh-Gli2 signaling, we wanted to examine the physiological significance of Hes1 as a Shh target gene. To investigate this, we used PtchlacZ+/- mice, which exhibit constitutive Hh pathway activation that results in delayed cell cycle exit in the central retina of postnatal mice (Black et al., 2003; Moshiri and Reh, 2004). To directly evaluate whether Hes1 is necessary for the Hh-mediated proliferation of progenitor cells in vivo, we generated PtchlacZ+/-Hes1+/- compound heterozygous mice. We chose to work with mice heterozygous for Ptch because Ptch-/- mutants exhibit early embryonic lethality before retinal development (Goodrich et al., 1997). Immunohistochemistry (IHC) for the mitotic marker pH3 revealed that mitotic cells were reduced in the compound heterozygous retinas (PtchlacZ+/-Hes1+/-) compared with retinas from PtchlacZ+/- mice (Fig. 5, a-c). Furthermore, quantification of BrdU incorporation from retinal sections of PtchlacZ+/-Hes1+/- double heterozygous animals revealed a significant reduction in the total number of cells in S phase compared with PtchlacZ+/- retinas, which demonstrates that Hes1 is a mediator of Shh-dependent proliferation in the retina in vivo (Fig. 5 d). Also, quantification of the proportion of BrdU-labeled cells from dissociated retinas revealed a significant increase in proliferation in PtchlacZ+/- retinas compared with the wild type; however, there was no significant increase in proliferation in PtchlacZ+/-Hes1+/- retinas (Fig. 5 e). This data provides novel evidence for an in vivo genetic interaction between Hh signaling and Hes1 in the regulation of progenitor cell proliferation.
###end p 31
###begin p 32
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Shh-mediated RPC proliferation and cell fate specification requires <italic>Hes1</italic>.</bold>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 190 201 190 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 207 225 207 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 456 457 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 468 471 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 464 471 463 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>+/&#8722;</sup></italic>
###xml 473 474 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 489 492 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 481 492 480 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 494 495 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 514 517 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 521 524 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 506 524 505 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 526 527 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 682 683 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 742 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 753 756 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 749 756 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>+/&#8722;</sup></italic>
###xml 758 759 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 774 777 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 766 777 765 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 779 780 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 799 802 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 806 809 805 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 791 809 790 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 811 812 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 863 866 862 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 859 866 858 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>&#8722;/&#8722;</sup></italic>
###xml 868 869 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 882 883 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 988 989 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 993 994 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
Shh-mediated RPC proliferation and cell fate specification requires Hes1. (a-c) In vivo anti-pH3 staining of the central retina adjacent to the optic nerve (asterisks) in P5 wild-type (Wt), PtchlacZ+/-, and PtchlacZ+/-Hes1+/- retinas. Arrows indicate pH3-positive cells. Note that pH3+ cells in the vicinity of the optic nerve are rare in Wt and compound heterozygous mice. Bar, 100 mum. (d) Quantitative analysis of BrdU incorporation in vivo from P5 Wt (n = 3), Hes1+/- (n = 3), PtchlacZ+/- (n = 3), and PtchlacZ+/-Hes1+/- (n = 6) retinas. Values represent the mean number of BrdU-positive cells counted from three sections per animal. (e) Quantification of the proportion of BrdU+ cells in single-cell dissociates from the retinas of Wt (n = 5), Hes1+/- (n = 3), PtchlacZ+/- (n = 8), and PtchlacZ+/-Hes1+/- (n = 7) retinas at P5. (f) Retinal explants from Hes1-/- (n = 3) or Wt (n = 3) animals were treated with a Smo agonist for 3 d, dissociated, and scored for the proportion of BrdU+DAPI+ cells. (g) Quantitative analysis for BrdU, CRALBP, Chx10, rhodopsin, and recoverin-positive cells in Smo agonist-treated P0 retinal explants electroporated with GFP and Hes1DN. Values are based on scoring marker+ cells among the transfected cohort in dissociates from retinal explants and represent the fold induction of double-positive (marker+GFP+) cells in GFP + Ag and Hes1DN + Ag cultures compared with double-positive cells in GFP-transfected untreated explants. There is no difference in proliferation or cell type composition in GFP and Hes1DN-transfected cells in untreated explants. Error bars represent SEM. *, P < 0.05; **, P < 0.01.
###end p 32
###begin p 33
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>&#8722;/&#8722;</sup></italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 216 224 216 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 f</xref>
###xml 532 550 532 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">Strom et al., 1997</xref>
###xml 1323 1331 1323 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 g</xref>
###xml 1572 1580 1572 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 q</xref>
We also investigated the proliferative response induced by Shh in Hes1-/- mutant retinal explants. Loss of Hes1 resulted in a significant decrease in Shh-mediated BrdU incorporation compared with wild-type explants (Fig. 5 f). To study whether acute inhibition of Hes1 activity antagonizes progenitor cell proliferation in response to Shh, we antagonized Hes1 activity using a previously characterized Hes1DN construct that carries three point mutations in the basic DNA-binding domain that interfere with its DNA-binding activity (Strom et al., 1997). The Hes1DN protein will dimerize with wild-type Hes1 and HesR proteins to form transcriptionally inactive complexes. Retinal explants were electroporated with the Hes1DN construct and cultured in the presence of a Smo agonist for 3 d in vitro. The explants were dissociated by enzymatic digestion followed by IHC for cell type-specific markers and scored for marker+ cells among the transfected cohort of cells, which was identified by GFP fluorescence. Normally, Smo agonist treatment of control electroporated RPCs results in an increased proportion of dividing progenitors compared with control explants (Fig. S3, available at ). BrdU incorporation in response to the agonist was reduced by 50% in the Hes1DN-expressing cohort compared with the GFP-expressing cells (Fig. 5 g), which indicates that Hes1 is required for Shh-mediated proliferation. This data also reinforces the hypothesis that Hes1 is a Notch-independent target of Shh, as inhibition of Notch signaling did not compromise Shh-induced proliferation (Fig. 2 q).
###end p 33
###begin p 34
###xml 126 143 126 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 145 160 145 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib69">Yu et al., 2006</xref>
###xml 266 285 266 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">Tomita et al., 1996</xref>
###xml 287 308 287 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Furukawa et al., 2000</xref>
###xml 310 332 310 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Takatsuka et al., 2004</xref>
###xml 887 895 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 g</xref>
The Shh pathway also promotes the development of Muller glia and bipolar cells at the expense of rod photoreceptors (Fig. S3; Wang et al., 2005; Yu et al., 2006). As Hes1 has been implicated as a regulatory factor in promoting bipolar and Muller cell specification (Tomita et al., 1996; Furukawa et al., 2000; Takatsuka et al., 2004), we investigated whether Hes1 was required for the acquisition of specific cell fates downstream of Shh signaling. Retinal explants were electroporated with the Hes1DN construct or GFP, cultured with the Smo agonist for 7 d in vitro, and dissociated and scored using IHC for specific cell type markers. Significantly, there was a 50% reduction in the proportion of Muller (anti-cellular retinaldehyde-binding protein [CRALBP]) and bipolar cells (anti-Chx10) in agonist-treated Hes1DN-expressing cells compared with agonist-treated GFP-expressing cells (Fig. 5 g). The reduction in cells with a bipolar and Muller cell identity in the Hes1DN cohort was associated with an increase in the proportion of cells positive for rod photoreceptor markers rhodopsin and recoverin. Therefore, the Muller- and bipolar-promoting effects of Shh require Hes1.
###end p 34
###begin title 35
Loss of Gli2 represses proliferation and cell fate specification in response to Shh signaling, similar to inhibition of Hes1
###end title 35
###begin p 36
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 359 366 359 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 434 440 434 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 503 506 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 573 579 573 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
###xml 762 766 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
Because Gli2 is necessary for the induction of Hes1 by Shh signaling, we asked whether loss of Gli2 phenocopies the effect of Hes1 inhibition in the context of an activated Shh pathway. Gli2-/- mutant explants at E18 were cultured with the Smo agonist and analyzed for proliferation and the development of specific cell types. Proliferation was attenuated in Gli2-/--treated explants relative to wild type-treated explants after 3 d (Fig. 6). Muller and bipolar cell development was also reduced in Gli2-/--treated explants cultured for 7 d compared with control explants (Fig. 6), which demonstrates that Gli2 is required for Shh effects on cell type development. In contrast, Hh-mediated proliferation was normal in the absence of Gli1 correlating with normal Hes1 induction (unpublished data).
###end p 36
###begin p 37
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 is required for the Shh effects on proliferation and cell fate.</bold>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Gli2 is required for the Shh effects on proliferation and cell fate. Retinal explants were cultured from wild-type (Wt; n = 3) and Gli2-/- (n = 3) mice at E18 for 3 d in culture with or without a Smo agonist. IHC was performed on dissociated cells using anti-BrdU, anti-CRALBP, anti-rhodopsin, and anti-recoverin antibodies. Values represent the fold induction of positive cells in Wt + Ag or Gli2-/- + Ag cultures compared with nontreated explants. Error bars represent SEM. *, P < 0.05; **, P < 0.01.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 532 554 532 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Takatsuka et al., 2004</xref>
###xml 556 575 556 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Jadhav et al., 2006</xref>
###xml 577 595 577 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">Yaron et al., 2006</xref>
###xml 656 660 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 664 670 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch1</italic>
###xml 675 685 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBPJ-&#954;</italic>
###xml 763 767 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 769 793 765 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">de la Pompa et al., 1997</xref>
###xml 795 816 791 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Furukawa et al., 2000</xref>
###xml 818 842 814 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">Stockhausen et al., 2005</xref>
###xml 844 863 840 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Nguyen et al., 2006</xref>
###xml 865 884 861 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Ingram et al., 2008</xref>
###xml 886 907 882 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Nakazaki et al., 2008</xref>
###xml 1005 1009 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1057 1061 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1118 1122 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1135 1154 1131 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Nelson et al., 2007</xref>
###xml 1228 1232 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1298 1302 1294 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1323 1343 1319 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">Solecki et al., 2001</xref>
###xml 1394 1398 1390 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1584 1588 1580 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 1593 1597 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1612 1616 1608 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 1854 1877 1838 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 1978 1997 1962 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Barolo et al., 2000</xref>
###xml 1999 2017 1983 2001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Beres et al., 2006</xref>
###xml 2019 2036 2003 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Hori et al., 2008</xref>
###xml 951 956 <span type="species:ncbi:9031">chick</span>
###xml 1854 1877 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 1906 1911 <span type="species:ncbi:10090">mouse</span>
In this study, we sought to identify the molecular mechanisms that Shh utilizes to regulate CNS progenitor cell behavior. We have used the neural retina as a model for CNS development to evaluate the mechanism and function of Hes1 as a putative Shh target gene. Hes1 is a key target of the Notch pathway, and its role during development is normally associated with activated Notch signaling. However, Hes1 mutant retinas do not mimic Notch1 mutants, which suggests that Hes1 may have Notch-independent roles in retinal development (Takatsuka et al., 2004; Jadhav et al., 2006; Yaron et al., 2006). This idea is corroborated by the persistent expression of Hes1 in Notch1 and RBPJ-kappa mutant embryos and the identification of other factors capable of activating Hes1 (de la Pompa et al., 1997; Furukawa et al., 2000; Stockhausen et al., 2005; Nguyen et al., 2006; Ingram et al., 2008; Nakazaki et al., 2008). Also, inhibition of the Notch pathway in chick retinal explants results in a weak reduction of Hes1 expression and a much more potent reduction in Hes5 levels, which is further evidence for Notch-independent Hes1 regulation (Nelson et al., 2007). Shh treatment of cerebellar granule precursors results in induction of Hes1, which suggests a more general role for Shh in the regulation of Hes1 in CNS development (Solecki et al., 2001). Here, we show that Gli2 is a novel regulator of Hes1 expression and that Hes1 is a novel mediator of Shh-mediated proliferation in neural progenitors. Surprisingly, we have observed a differential mechanism for Shh-mediated regulation of Hes1 and Hes5. Induction of Hes5 is independent of Notch; however, it requires signaling by RBPJ-kappa, suggesting that RBPJ-kappa can function independently of Notch downstream of Shh activation. To date, Notch-independent RBPJ-kappa activity has only been reported in Drosophila melanogaster mechanoreceptor physiology, mouse pancreas development, and the specification of GABAergic neurons (Barolo et al., 2000; Beres et al., 2006; Hori et al., 2008).
###end p 39
###begin p 40
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 325 344 325 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Nelson et al., 2007</xref>
###xml 647 650 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 643 650 643 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>+/&#8722;</sup></italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 771 778 771 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>&#8722;/&#8722;</sup></italic>
###xml 788 810 788 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Takatsuka et al., 2004</xref>
###xml 1034 1063 1034 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Matter-Sadzinski et al., 2005</xref>
###xml 1115 1134 1115 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Hirata et al., 2002</xref>
###xml 1320 1340 1320 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">Shimojo et al., 2008</xref>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
The requirement for both Shh- and Notch-driven regulation of Hes1 in progenitor cells may be explained by several hypotheses. First, Shh and Notch could be targeting different progenitor populations. A recent study has shown that the activated NICD is heterogeneously expressed in subsets of progenitors in the mouse retina (Nelson et al., 2007), which implies that not all progenitors are responsive to activated Notch signaling. Second, progenitor cells are sensitive to Hes1 dosage; therefore, Notch and Shh signaling may be required to achieve the spectrum of Hes1 levels needed for cell fate specification and proliferation. For example, Hes1+/- retinas exhibit accelerated rod photoreceptor differentiation without the proliferative or RGC phenotype characterizing Hes1-/- retinas (Takatsuka et al., 2004). Also, the decision to adopt an RGC fate is dependent on levels of proneuronal bHLHs NGN2 and Math5 as well as Hes1, with high levels of Hes1 antagonizing Math5 expression and function and thereby inhibiting the RGC fate (Matter-Sadzinski et al., 2005). Mechanistically, oscillation in Hes1 expression (Hirata et al., 2002) could be one way to achieve functionally relevant modulations in Hes1 levels in progenitor cells. Notch-induced Hes1 oscillation is required for the maintenance of neural progenitors (Shimojo et al., 2008), and it is conceivable that the effects of Hh signaling on Hes1 expression could be mediated by a similar mechanism. Further analysis is necessary to determine the mode of Hes1 expression in the context of Hh pathway activation.
###end p 40
###begin p 41
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 708 727 708 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Matise et al., 1998</xref>
###xml 729 750 729 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Corrales et al., 2004</xref>
###xml 752 781 752 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Palma and Ruiz i Altaba, 2004</xref>
###xml 783 803 783 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Hutchin et al., 2005</xref>
###xml 805 820 805 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Hu et al., 2006</xref>
###xml 822 840 822 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib70">Zhang et al., 2008</xref>
###xml 1130 1134 1130 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
We have identified a direct interaction of Gli2 and Hes1 at two Gli consensus sites in the Hes1 promoter. In these studies, we obtained strong evidence for a direct effect because ChIP analysis using primary RPCs revealed Shh-dependent recruitment of Gli2 to the Hes1 promoter in vivo. These findings, coupled with our strong genetic evidence linking Shh to Hes1, provide the first example of an interaction between Gli2 signaling and Hes1 expression, and the first example of the importance of this mechanism in the regulation of progenitor cell proliferation. Our findings also raise the possibility that Gli2-dependent regulation of proliferation in other tissues could function with a similar mechanism (Matise et al., 1998; Corrales et al., 2004; Palma and Ruiz i Altaba, 2004; Hutchin et al., 2005; Hu et al., 2006; Zhang et al., 2008). In addition to activator Gli1 and Gli2 function, the Gli3 transcription factor is also a mediator of the Shh pathway, and it functions to repress target genes in the absence of Shh signaling. Because loss of function of both Gli1 and Gli2 completely attenuates Shh-mediated induction of Hes1, it appears that derepression of Gli3 is not a primary regulator in this context.
###end p 41
###begin p 42
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 149 164 149 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. melanogaster</italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hairy</italic>
###xml 308 325 308 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Hays et al., 1999</xref>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hairy</italic>
###xml 408 423 408 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. melanogaster</italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hairy</italic>
###xml 514 531 514 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Hays et al., 1999</xref>
###xml 592 607 592 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. melanogaster</italic>
###xml 679 697 679 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Fu and Baker, 2003</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hairy</italic>
###xml 149 164 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 408 423 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 592 607 <span type="species:ncbi:7227">D. melanogaster</span>
Hh control of Hes1 appears to be an evolutionary conserved signaling mechanism involved in widespread tissue patterning. Hh drives expression of the D. melanogaster homologue of Hes1, hairy, along the dorsal/ventral axis of the leg imaginal disc to negatively regulate the development of sensory cell fates (Hays et al., 1999). The induction of hairy in response to Hh requires Cubitus interruptus (Ci), the D. melanogaster homologue of Gli, and dorsal/ventral expression of hairy is lost in Smo-deficient clones (Hays et al., 1999). Patterning of the retinal field during development of the D. melanogaster compound eye also reveals Notch-independent regulation of hairy by Hh (Fu and Baker, 2003). In this system, both Hh and Notch negatively regulate hairy expression to promote a wave of photoreceptor differentiation.
###end p 42
###begin p 43
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
In this study, we have elucidated a novel mechanism for Shh-controlled progenitor cell behavior. Our observation that Gli2 occupies the Hes1 promoter is one of the first identified direct relationships between Gli2 and a target gene in neural progenitor cells. This study provides a mechanistic link between Shh-Gli2 signaling and Hes1 in regulating the proliferation of RPCs, thereby shedding light on a new means of manipulating Shh-induced cellular responses.
###end p 43
###begin title 44
Materials and methods
###end title 44
###begin title 45
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice
###end title 45
###begin p 46
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 56 67 56 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 74 95 74 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Goodrich et al., 1997</xref>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>+/&#8722;</sup></italic>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>+/&#8722;</sup></italic>
###xml 270 285 270 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Mo et al., 1997</xref>
###xml 287 304 287 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Park et al., 2000</xref>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 311 318 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>+/&#8722;</sup></italic>
###xml 320 342 320 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Ishibashi et al., 1995</xref>
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 381 392 381 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup></italic>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 410 417 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1<sup>+/&#8722;</sup></italic>
###xml 469 472 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 461 479 461 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PtchlacZ<sup>+/&#8722;</sup>Hes1<sup>+/&#8722;</sup></italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>+/&#8722;</sup></italic>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2<sup>+/&#8722;</sup></italic>
###xml 566 569 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 562 576 562 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>+/&#8722;</sup>Gli2<sup>+/&#8722;</sup></italic>
###xml 650 653 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 657 660 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 646 660 646 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1<sup>&#8722;/&#8722;</sup>Gli2<sup>&#8722;/&#8722;</sup></italic>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
Several transgenic mouse lines were used in this study. PtchlacZ+/- mice (Goodrich et al., 1997) were obtained from the Jackson Laboratory and maintained on a C57Bl6 background; Gli1+/- and Gli2+/- mice (obtained from A. Joyner, Sloan-Kettering Institute, New York, NY; Mo et al., 1997; Park et al., 2000), and Hes1+/- (Ishibashi et al., 1995) were maintained on a CD1 background. PtchlacZ+/-were crossed with Hes1+/- mice to generate double heterozygous mice (PtchlacZ+/-Hes1+/-). Gli1+/- and Gli2+/- strains were mated to generate double heterozygous animals, Gli1+/-Gli2+/-, which were subsequently crossed to give double homozygous null mice Gli1-/-Gli2-/-. Unless otherwise stated, retinal explants were derived from CD1 (the Jackson Laboratory) wild-type mice.
###end p 46
###begin title 47
Cell culture, retinal explants, and BrdU labeling
###end title 47
###begin p 48
###xml 218 235 218 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 343 372 343 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Frank-Kamenetsky et al., 2002</xref>
###xml 424 425 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 914 931 906 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Wang et al., 2005</xref>
###xml 1108 1127 1100 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Sasaki et al., 1999</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains were continuously mated or time-mated to generate specimens of the appropriate age, with the day of the vaginal plug designated day 0 of gestation. Retinal explants were prepared as described previously (Wang et al., 2005). Retinal explant medium was supplemented with 10 nM of Smo agonist (Ag1.10; a kind gift from Curis, Inc.; Frank-Kamenetsky et al., 2002) or 10 muM DAPT (Millipore), then cultured at 8% CO2 and 37degreesC. Selected explants were labeled with 10 muM BrdU for the last 6 h of culture to identify cells in S phase. Explants were either fixed in a 4% paraformaldehyde phosphate buffer for 1 h, transferred to a 30% sucrose/PBS solution overnight, and embedded in 1:1 optimal cutting temperature/30% sucrose/PBS mixture or dissociated into single cells with trypsin (Sigma-Aldrich) and plated onto Superfrost slides (Sigma-Aldrich) for quantitative analysis as described previously (Wang et al., 2005). COS cells were cultured in 10% FBS DME and transfected with full-length Myc-tagged Gli2 (a gift from H. Sasaki, RIKEN Center for Developmental Biology, Chuo-ku, Kobe, Japan; Sasaki et al., 1999) or pUb-GFP (a gift from T. Matsuda, Harvard Medical School, Boston, MA) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
###end p 48
###begin title 49
Histology, IHC, and ISH
###end title 49
###begin p 50
###xml 50 74 50 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Jensen and Wallace, 1997</xref>
###xml 76 89 76 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">Wallace, 1999</xref>
###xml 91 110 91 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Dakubo et al., 2003</xref>
###xml 315 335 315 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">R&#246;hlich et al., 1989</xref>
###xml 151 157 <span type="species:ncbi:9986">rabbit</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 338 344 <span type="species:ncbi:9986">rabbit</span>
###xml 384 389 <span type="species:ncbi:9940">sheep</span>
###xml 500 506 <span type="species:ncbi:9986">rabbit</span>
###xml 553 559 <span type="species:ncbi:9986">rabbit</span>
###xml 623 629 <span type="species:ncbi:9793">donkey</span>
###xml 635 639 <span type="species:ncbi:9925">goat</span>
###xml 662 666 <span type="species:ncbi:9925">goat</span>
###xml 672 678 <span type="species:ncbi:9986">rabbit</span>
###xml 702 706 <span type="species:ncbi:9925">goat</span>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
###xml 769 773 <span type="species:ncbi:9925">goat</span>
###xml 779 785 <span type="species:ncbi:9986">rabbit</span>
IHC or ISH was performed as described previously (Jensen and Wallace, 1997; Wallace, 1999; Dakubo et al., 2003). Antibodies used in this study include rabbit polyclonal anti-CRALBP (a kind gift from J. Saari, University of Washington, Seattle, WA), mouse monoclonal anti-BrdU (BD), mouse monoclonal anti-rhodopsin (Rohlich et al., 1989), rabbit polyclonal anti-recoverin (Millipore), sheep polyclonal anti-Chx10 (a gift from R. Bremner, Toronto Western Research Institute, Toronto, Ontario, Canada), rabbit polyclonal phosphohistone H3 (Millipore), and rabbit polyclonal anti-GFP (Invitrogen). Secondary antibodies include donkey anti-goat IgG Cy3 (Invitrogen), goat anti-rabbit IgG FITC (Invitrogen), goat anti-mouse IgG Cy3 (Jackson ImmunoResearch Laboratories), and goat anti-rabbit IgG Cy3 (Jackson ImmunoResearch Laboratories). The antisense riboprobes used for ISH include Gli1 (a gift from A. Joyner), RBPJ-kappa (a gift from T. Hongo, Kyoto University, Kyoto, Japan), Gli2 (a gift from H. Sasaki), Hes1, and Hes5. Bright field images were analyzed using an Axioplan microscope and captured with an Axiovision camera (2.05; both from Carl Zeiss, Inc.). Pictures were taken at magnifications of 10x (NA 0.30) and 20x (NA 0.05; both from Carl Zeiss, Inc.). Fluorescent images were analyzed using an Axiocam microscope (HRm) and captured with an Axioimager camera (M1; both from Carl Zeiss, Inc.). Florescent images were taken at 20x (0.8 NA). All images were processed using Photoshop CS2 (Adobe).
###end p 50
###begin title 51
In vitro electroporation
###end title 51
###begin p 52
###xml 77 101 77 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Matsuda and Cepko (2004)</xref>
Electroporation was performed on retinal explants based on the protocol from Matsuda and Cepko (2004). Explanted retinas were electroporated (ECM 830; BTX Harvard Apparatus) in a 2-mm gap cuvette (VWR) with 0.5-1.5 mug/mul of plasmid DNA in endotoxin-free TE buffer with a 10:1 ratio of plasmid DNA/pUb-GFP or pUb-GFP alone. The DNA plasmids used in this study include: SMO-M2 (a gift from G. Fishell, New York University Langone Medical Center, New York, NY), an activated NICD (a gift from G. Weinmaster, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA), LacZ 2.1 double-stranded shcontrol (Invitrogen), shRBPJ-k (Invitrogen), and Hes1DN.
###end p 52
###begin title 53
Western blotting
###end title 53
###begin p 54
###xml 218 237 218 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Dakubo et al., 2008</xref>
###xml 281 287 <span type="species:ncbi:9986">rabbit</span>
###xml 413 417 <span type="species:ncbi:9925">goat</span>
###xml 501 507 <span type="species:ncbi:9986">rabbit</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 664 668 <span type="species:ncbi:9925">goat</span>
###xml 674 680 <span type="species:ncbi:9986">rabbit</span>
###xml 715 721 <span type="species:ncbi:9793">donkey</span>
###xml 727 731 <span type="species:ncbi:9925">goat</span>
###xml 783 788 <span type="species:ncbi:9940">sheep</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
Protein was extracted from Smo agonist-treated and nontreated retinal explant cultures using RIPA buffer (125 mM Tris-HCL, 2% SDS + protease inhibitor cocktail), and Western blotting performed as described previously (Dakubo et al., 2008). Protein samples were probed with 1:1,500 rabbit polyclonal anti-Hes1 (a gift from N. Brown, University of Cincinnati College of Medicine, Cincinnati, OH), 1:200 dilution of goat polyclonal anti-Gli2 (sc-20291; Santa Cruz Biotechnology, Inc.), 1:500 dilution of rabbit polyclonal Gli2 (Abcam), or 1:50 dilution of mouse monoclonal antibody E7 ascites (Developmental Studies Hybridoma Bank). Secondary antibodies used include goat anti-rabbit IgG HRP (1:5,000; Sigma-Aldrich), donkey anti-goat HRP (1:3,000; Santa Cruz Biotechnology, Inc.), and sheep anti-mouse IgG HRP (1:3,000; Sigma-Aldrich).
###end p 54
###begin title 55
RT-qPCR
###end title 55
###begin p 56
###xml 1045 1052 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Ct</sup>
###xml 1256 1257 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
RNA was harvested from Smo agonist-treated and nontreated retinal explants using Trizol (1 explant per 1 ml of Trizol). cDNA was synthesized using 2 mug of total RNA with the Invitrogen kit according to the manufacturer's instructions. qPCR was performed using 1 mul of cDNA with Brillant SyBr Green mastermix (Agilent Technologies) according to the manufacturer's instructions, with the exception that the reaction was scaled down to a total volume of 25 mul. Primers (200 nM) used include Hes1 (forward, 5'-AAAGACGGCCTCTGAGCACA-3'; reverse, 5'-TCATGGCGTTGATCTGGGTCA-3'), Hes5 (forward, 5'-AAGAGCCTGCACCAGGACTA-3'; reverse, 5'-CGCTGGAAGTGGTAAAGCA-3'), and 18S (forward, 5'-CGGCTACCACATCCAAGG-3'; reverse, 5'-CTGGAATTACCGCGGCT-3'), and GFP (forward, 5'-CGTCGCCGTCCAGCTCGACCAG-3'; reverse, 5'-CATGGTCCTGCTGGAGTTCGTG-3'), Gli1 (forward, 5'-CACTACCTGGCCTCACACCT-3'; reverse, 5'-GTACTCGGTTCGGCTTCTCC-3'). The PCR reaction was performed on a MX3000P (Stratagene) with 40 amplification cycles. Changes in gene expression were quantified based on the 2DeltaCt value normalized to 18S. Normalization to GFP was used to standardize for transfection efficiency in electroporated retinal explants. Statistical significance was determined using a two-tailed student's t test.
###end p 56
###begin title 57
ChIP
###end title 57
###begin p 58
###xml 77 93 77 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Lai et al., 2004</xref>
###xml 1433 1440 1425 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Ct</sup>
###xml 1630 1631 1614 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 607 611 <span type="species:ncbi:9925">goat</span>
###xml 722 726 <span type="species:ncbi:9925">goat</span>
Candidate Gli consensus sequences were identified as GACCACCCA or TGGGTGGTC (Lai et al., 2004), and primers were designed to amplify regions of genomic DNA that contain at least a seven-base match within a 10-kb region of the Hes1 promoter. CD1 retinal explants treated with or without a Smo agonist for 3 d were fixed in cold 4% paraformaldehyde PBS solution (two explants per condition) for 30 min. The DNA was sheared to less than 1 kb by sonication. ChIP was performed using the EZ ChIP kit (Millipore) according to the manufacturer's instructions. Immunoprecipitations were performed using 10 mul of a goat anti-Gli2 polyclonal antibody (Santa Cruz Biotechnology, Inc.) or an irrelevant antibody of the same species (goat anti-Brn3b). DNA was analyzed using qPCR with 2 mul of DNA with Brilliant SyBr green mastermix (Stratagene) and 200 nM of Hes1 primers (-7,808 bp site: forward, 5'-CAGTGCTACAGACCACACAGG-3'; and reverse, 5'-AGAACGTGACATCGGCTTTC-3'; -146 bp site: forward, 5'-TCCTTTTGATTGACGTTGTAGC-3'; and reverse, 5'-CCCAAACTTTCTTTCCCACA-3'), with an annealing temperature of 60degreesC on a MX3000P for 40 cycles. A primer set (forward, 5'-TTGAGGGTTTTTGTTTTGTTTTG-3'; reverse, 5'-CGGTTGCTTTTTAAACAGTGG-3') spanning a region of the Hes1 promoter without a Gli consensus sequence was used as a negative control. The Ct values were expressed relative to unprecipitated input chromatin and fold enrichment were calculated by 2DeltaCt, where DeltaCt = Ct (anti-Gli2 - anti-control Brn3b). Standard deviation was calculated based on three independent experiments, and significance was calculated using a two-tailed student's t test.
###end p 58
###begin title 59
Online supplemental material
###end title 59
###begin p 60
###xml 101 105 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes1</italic>
###xml 110 114 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli1</italic>
Fig. S1 shows knockdown of Hes1 reporter activity in response to shRBPJ-kappa. Fig. S2 confirms that Hes1 and Gli1 levels are maintained in retinal explant cultures after a culture period of 6 h. Fig. S3 shows the proportions of retinal cell types in response to Smo Ag treatment. Online supplemental material is available at .
###end p 60
###begin title 61
Supplementary Material
###end title 61
###begin title 62
[Supplemental Material Index]
###end title 62
###begin p 63
We are grateful to Izhar Livnebar for technical advice on ChIP; and R. Bremner, Ruth Slack, Lynn Megeney, and Ilona Skerjanc for critical reading of the manuscript.
###end p 63
###begin p 64
Dana Wall is a recipient of a Canadian Institutes of Health Research/CNIB studentship award. This work was supported by an operating grant to V. Wallace from the Canadian Cancer Society (National Cancer Institute of Canada grant 016435).
###end p 64

